This document discusses viaticals, which are financial products that allow terminally ill individuals to receive money based on the value of their life insurance policies. It summarizes the regulatory approaches and industry practices regarding viaticals in Canada and the United States. It also compares the loan and settlement models for viaticals and discusses the advantages of non-profit versus for-profit companies in this industry from the perspective of policyholders, consumer groups, and social responsibility.